|
Index of reports
> Serious Reactions (883)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel serious reactions. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 883 Next >>
Possible Paclitaxel side effects in 57 year old female
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-08-27
Patient: 57 year old female
Reactions: Breast Cancer Metastatic, Paraneoplastic Dermatomyositis, Pulmonary Embolism
Adverse event resulted in: death
Drug(s) suspected as cause:
Capecitabine
Administration route: Oral
Indication: Breast Cancer
Cisplatin
Dosage: 6 cycles
Indication: Breast Cancer
Cyclophosphamide
Dosage: 6 cycles
Indication: Breast Cancer
Doxorubicin Hydrochloride
Dosage: 6 cycles
Indication: Breast Cancer
Gemcitabine Hydrochloride
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Possible Paclitaxel side effects in 72 year old female
Reported by a physician from United States on 2012-08-27
Patient: 72 year old female, weighing 71.6 kg (157.5 pounds)
Reactions: Ventricular Arrhythmia
Drug(s) suspected as cause:
Avastin
Dosage: 15 mg/kg iv over 30-90 minutes on day 1 on 2 cycle onwards
Indication: Ovarian Epithelial Cancer
Carboplatin
Dosage: auc 6 (cycle 1-6),6th cycle completed on 16/feb/2012
Indication: Ovarian Epithelial Cancer
Start date: 2011-11-23
Ipratropium Bromide
Indication: Product Used FOR Unknown Indication
Paclitaxel
Dosage: 175 mg/m2 over 3 hrs on day 1(cycle 1-6), 6th cycle completed on 16/feb/2012
Indication: Ovarian Epithelial Cancer
Start date: 2011-11-23
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 2.5 kg (5.4 pounds)
Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage III
Cytoxan
Indication: Breast Cancer Stage III
Paclitaxel
Indication: Breast Cancer Stage III
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 2.1 kg (4.7 pounds)
Reactions: Hyperbilirubinaemia
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Paclitaxel
Indication: Breast Cancer Stage II
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Premature Rupture of Membranes, Maternal Exposure During Pregnancy, Uterine Contractions During Pregnancy
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage I
Cytoxan
Indication: Breast Cancer Stage I
Paclitaxel
Indication: Breast Cancer Stage I
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 1.9 kg (4.1 pounds)
Reactions: Foetal Growth Restriction, Foetal Exposure During Pregnancy
Drug(s) suspected as cause:
Carboplatin
Indication: Ovarian Cancer Stage I
Paclitaxel
Indication: Ovarian Cancer Stage I
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Paclitaxel
Indication: Breast Cancer Stage II
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 2.4 kg (5.3 pounds)
Reactions: Neutropenia Neonatal, Pyloric Stenosis
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage III
Cytoxan
Indication: Breast Cancer Stage III
Docetaxel
Indication: Breast Cancer Stage III
Paclitaxel
Indication: Breast Cancer Stage III
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient:
Reactions: Asperger's Disorder, Jaundice, Hyperbilirubinaemia, Speech Disorder Developmental, Foetal Exposure During Pregnancy, Tourette's Disorder, Dyslexia
Drug(s) suspected as cause:
Cisplatin
Indication: Ovarian Cancer Stage I
Paclitaxel
Indication: Ovarian Cancer Stage I
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 1.4 kg (3.1 pounds)
Reactions: Selective IGA Immunodeficiency, Neonatal Respiratory Distress Syndrome, Premature Baby, Gastrooesophageal Reflux Disease, Apnoea, Constipation
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Paclitaxel
Indication: Breast Cancer Stage II
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Maternal Exposure During Pregnancy, Uterine Contractions During Pregnancy
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage I
Cytoxan
Indication: Breast Cancer Stage I
Fluorouracil
Indication: Breast Cancer Stage I
Paclitaxel
Indication: Breast Cancer Stage I
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Paclitaxel
Indication: Breast Cancer Stage II
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: , weighing 1.9 kg (4.3 pounds)
Reactions: Foetal Growth Restriction
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage I
Cytoxan
Indication: Breast Cancer Stage I
Fluorouracil
Indication: Breast Cancer Stage I
Paclitaxel
Indication: Breast Cancer Stage I
Possible Paclitaxel side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Pneumocystis Jiroveci Pneumonia, Maternal Exposure During Pregnancy, Neutropenia, Premature Labour
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Paclitaxel
Indication: Breast Cancer Stage II
Possible Paclitaxel side effects in female
Reported by a physician from Italy on 2012-08-22
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Atrial Fibrillation
Drug(s) suspected as cause:
Herceptin
Dosage: maintanence dose
Herceptin
Dosage: date of last dose prior to sae: 10/jul/2012, loading dose
Indication: Breast Cancer
Start date: 2012-05-28
Paclitaxel
Dosage: date of last dose prior to sae:10/jul/2012
Indication: Breast Cancer
Start date: 2012-05-28
End date: 2012-07-10
Paclitaxel
Start date: 2012-07-31
Pertuzumab
Dosage: maintanance dose
Pertuzumab
Dosage: date of last dose prior to sae was 10/jul/2012, loading dose
Indication: Breast Cancer
Start date: 2012-05-28
Other drugs received by patient: Bisoprolol Fumarate; Epirubicin; Fluorouracil
Possible Paclitaxel side effects in female
Reported by a physician from South Africa on 2012-08-22
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Renal Impairment, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: unk
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Comparator Trastuzumab
Dosage: 2 mg/kg, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Paclitaxel
Dosage: 80 mg/m2, qw
Indication: Breast Cancer Metastatic
Start date: 2010-08-10
Other drugs received by patient: Zamanon; Marinol; Metformin; Maxolon
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-08-22
Patient: female, weighing 89.0 kg (195.8 pounds)
Reactions: Alanine Aminotransferase Increased, Liver Disorder
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-02
Lapatinib
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-06-21
Npld (Non-Pegylated Liposomal Doxorubicin)
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-23
Paclitaxel
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-23
Trastuzumab
Indication: Breast Cancer
Start date: 2012-06-04
End date: 2012-07-02
Other drugs received by patient: Fraxiparina
Possible Paclitaxel side effects in 40 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-21
Patient: 40 year old female
Reactions: Generalised Erythema, Scotoma, Erythema, Abdominal Pain Upper
Drug(s) suspected as cause:
Paclitaxel
Other drugs received by patient: Ranitidine HCL; Epirubicin Hydrochloride; Ondansetron; Trimeton / 00072502 /; Solu-Cortef
Possible Paclitaxel side effects in 71 year old female
Reported by a physician from United States on 2012-08-21
Patient: 71 year old female
Reactions: Tongue Neoplasm Malignant Stage Unspecified
Drug(s) suspected as cause:
Carboplatin
Dosage: four cycles
Indication: Ovarian Cancer Recurrent
Start date: 2006-01-01
End date: 2006-01-01
Cisplatin
Indication: Ovarian Cancer
Doxorubicin Hydrochloride
Indication: Ovarian Cancer Recurrent
Start date: 2006-05-01
Doxorubicin Hydrochloride
Dosage: four cycles
Start date: 2006-01-01
End date: 2006-01-01
Paclitaxel
Indication: Ovarian Cancer
Possible Paclitaxel side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female
Reactions: LIP and / or Oral Cavity Cancer
Drug(s) suspected as cause:
Carboplatin
Dosage: completed 6 cycles
Indication: Ovarian Cancer Recurrent
Doxorubicin Hydrochloride
Dosage: after 6 cycles induction, maintained on doxorubicin for approximately 11 years
Indication: Ovarian Cancer Recurrent
Paclitaxel
Dosage: completed 6 cycles
Indication: Ovarian Cancer Recurrent
Topotecan Hydrochloride
Dosage: completed 6 cycles
Indication: Ovarian Cancer Recurrent
Possible Paclitaxel side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient: 44 year old female
Reactions: Squamous Cell Carcinoma, Carbohydrate Antigen 125 Increased, Thrombocytopenia
Drug(s) suspected as cause:
ABT-888
Administration route: Oral
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Carboplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Cisplatin
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-10
Cyclophosphamide
Indication: Ovarian Cancer
Start date: 2010-06-01
End date: 2011-04-01
Doxorubicin Hydrochloride
Dosage: maintenance dose for a total cumulative dose of 1.696 mg
Indication: Ovarian Cancer
End date: 2010-04-01
Doxorubicin Hydrochloride
Dosage: 3 cycles given
Start date: 2007-07-13
End date: 2007-09-14
Paclitaxel
Dosage: x 3 days for 4 cycles
Indication: Ovarian Cancer
Start date: 2007-07-13
End date: 2007-09-14
Topotecan Hydrochloride
Start date: 2005-08-29
Topotecan Hydrochloride
Dosage: for 4 cycles
Indication: Ovarian Cancer
Start date: 2005-06-14
End date: 2005-08-02
Possible Paclitaxel side effects in 71 year old female
Reported by a pharmacist from Brazil on 2012-08-20
Patient: 71 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Back Pain, Hyperaemia, Hypertension, Deep Vein Thrombosis
Drug(s) suspected as cause:
Paclitaxel
Other drugs received by patient: Dexamethasone; Ranitidine; Ondansetron; Diphenhydramine Hydrochloride
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-08-20
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Fatigue, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bevacizumab
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Carboplatin
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Paclitaxel
Indication: Breast Cancer
Start date: 2012-05-18
End date: 2012-08-09
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient:
Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose
Lapatinib
Dosage: arm b
Administration route: Oral
Indication: Breast Cancer
Lapatinib
Dosage: arm c
Administration route: Oral
Paclitaxel
Indication: Breast Cancer
Possible Paclitaxel side effects in female
Reported by a physician from Germany on 2012-08-16
Patient: female, weighing 59.0 kg (129.8 pounds)
Reactions: Palmar-Plantar Erythrodysaesthesia Syndrome, Nail Disorder
Drug(s) suspected as cause:
Avastin
Dosage: last dose prior to sae 05/oct/2011
Indication: Breast Cancer Metastatic
Start date: 2011-06-23
End date: 2011-10-05
Paclitaxel
Start date: 2011-07-17
End date: 2011-10-19
Paclitaxel
Dosage: date of last dose: 19/oct/2011
Indication: Breast Cancer Metastatic
Start date: 2011-06-23
End date: 2011-07-11
Other drugs received by patient: Gabapentin; Pamidronate Disodium; Effortil Plus; Omeprazole; Maaloxan; Pamidronate Disodium; Lasix; Ibuprofen; Xylocaine; Dexpanthenol; Ramiclair
Possible Paclitaxel side effects in 77 year old female
Reported by a physician from Poland on 2012-08-16
Patient: 77 year old female
Reactions: Diarrhoea, Conjunctivitis, Oedema, Rhinitis, Palmar-Plantar Erythrodysaesthesia Syndrome
Drug(s) suspected as cause:
Capecitabine
Indication: Breast Cancer
Start date: 2010-10-01
Lapatinib
Administration route: Oral
Indication: Breast Cancer
Start date: 2010-10-01
Paclitaxel
Indication: Breast Cancer
Start date: 2010-04-01
Other drugs received by patient: Trastuzumab; Acetylsalicylic Acid SRT
Possible Paclitaxel side effects in 52 year old female
Reported by a physician from Germany on 2012-08-14
Patient: 52 year old female, weighing 71.0 kg (156.2 pounds)
Reactions: Retinal Exudates, Visual Impairment
Drug(s) suspected as cause:
Paclitaxel
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-13
Patient:
Reactions: Dyspnoea, Brain Natriuretic Peptide Increased, Ejection Fraction Decreased, Nail Disorder, Cardiac Failure Congestive, Infusion Related Reaction
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 40-60 mg/m2 for fac and 60 mg/m2 for ac
Indication: Breast Cancer
Cyclophosphamide
Dosage: 500 mg/m2 for fac regimen and 600 mg/m2 for ac regimen
Indication: Breast Cancer
Docetaxel
Indication: Breast Cancer
Doxorubicin Hydrochloride
Dosage: 40-60 mg/m2 for fac and 60 mg/m2 for ac
Indication: Breast Cancer
Epirubicin
Dosage: 75-100 mg/m2
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Trastuzumab
Dosage: 8 mg/kg followed by maintenance (md) 6 mg/kg every 3 wks or 4 mg/kg followed by 2 mg/kg weekly md
Indication: Breast Cancer
Possible Paclitaxel side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10
Patient: 71 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 98 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2010-01-12
Paclitaxel
Dosage: 343 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2010-01-12
Other drugs received by patient: Prednisone TAB; Symbicort; Spiriva
Possible Paclitaxel side effects in
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10
Patient:
Reactions: Visual Impairment, Retinal Exudates
Drug(s) suspected as cause:
Paclitaxel
Page 1 Next >>
|
